Stress‐Responsive Gene FK506‐Binding Protein 51 Mediates Alcohol‐Induced Liver Injury Through the Hippo Pathway and Chemokine (C‐X‐C Motif) Ligand 1 Signaling

Background and Aims Chronic alcohol drinking is a major risk factor for alcohol‐associated liver disease (ALD). FK506‐binding protein 51 (FKBP5), a cochaperone protein, is involved in many key regulatory pathways. It is known to be involved in stress‐related disorders, but there are no reports regarding its role in ALD. This present study aimed to examine the molecular mechanism of FKBP5 in ALD. Approach and Results We found a significant increase in hepatic FKBP5 transcripts and protein expression in patients with ALD and mice fed with chronic‐plus‐single binge ethanol. Loss of Fkbp5 in mice protected against alcohol‐induced hepatic steatosis and inflammation. Transcriptomic analysis revealed a significant reduction of Transcriptional enhancer factor TEF‐1 (TEA) domain transcription factor 1 ( Tead1 ) and chemokine (C‐X‐C motif) ligand 1 ( Cxcl1 ) mRNA in ethanol‐fed Fkbp5−/− mice. Ethanol‐induced Fkbp5 expression was secondary to down‐regulation of methylation level at its 5′ untranslated promoter region. The increase in Fkbp5 expression led to induction in transcription factor TEAD1 through Hippo signaling pathway. Fkbp5 can interact with yes‐associated protein (YAP) upstream kinase, mammalian Ste20‐like kinase 1 (MST1), affecting its ability to phosphorylate YAP and the inhibitory effect of hepatic YAP phosphorylation by ethanol leading to YAP nuclear translocation and TEAD1 activation. Activation of TEAD1 led to increased expression of its target, CXCL1, a chemokine‐mediated neutrophil recruitment, causing hepatic inflammation and neutrophil infiltration in our mouse model. Conclusions We identified an FKBP5‐YAP‐TEAD1‐CXCL1 axis in the pathogenesis of ALD. Loss of FKBP5 ameliorates alcohol‐induced liver injury through the Hippo pathway and CXCL1 signaling, suggesting its potential role as a target for the treatment of ALD.